The Ultimate Growth Stock to Buy With $20 Right Now [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
But don't get discouraged; that money can go a long way if you know where to put it. Yes, even in the stock market, you can still get a lot for $20. Red-hot telehealth company Hims & Hers Health (NYSE: HIMS) recently exploded to nearly $20 per share on a major product announcement. Here's why this is arguably the best stock you can buy for $20 on Wall Street, and the party could just be getting started. The arrival of GLP-1 agonists GLP-1 agonists like Ozempic have taken the healthcare world by storm . These products mimic a hormone that helps suppress appetite and regulate blood sugar, two fundamental aspects of weight loss. Hims & Hers Health recently announced it would start carrying name-brand GLP-1 agonists and offering customized compounds containing active ingredients. The compounds are a big deal because they're significantly cheaper than the name-brand drugs, as much as 85% less The cost savings will attract consumers, especially since Hims & Hers doesn't require he
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers defended at BofA as Lilly fights compounded GLP-1s [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $22.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $17.25 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health Stock Soared This Week: Here's Why [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 6/20/24 - Form 144
- 6/18/24 - Form 4
- 6/18/24 - Form 4
- HIMS's page on the SEC website